Redlen Technologies

Redlen Technologies is a developer and manufacturer of multi-energy, radiation imaging modules based on its proprietary Cadmium Zinc Telluride (CZT) semiconductor technology. The company utilizes advanced in-house processes to grow CZT crystals and fabricate photon-counting sensors that combine semiconductor material with sophisticated electronics. These sensors are designed to measure the energy of individual X-ray photons, enabling superior spectral resolution and higher contrast-to-noise ratios compared to traditional scintillator-based detectors. By providing smaller pixel sizes and improved spatial resolution, Redlen’s modules facilitate ultra-high-resolution imaging while simultaneously reducing the radiation dose required for clinical and security applications.

Founded in 1999 and headquartered in Saanichton, British Columbia, the company serves as a merchant supplier to medical, security, and non-destructive testing markets. Acquired by Canon Inc. in 2021, Redlen operates as a wholly owned subsidiary, leveraging Canon’s manufacturing scale and automation capabilities to transition from prototype development to the mass production of its radiation detection solutions. The technology is critical for advancing next-generation medical systems, particularly Photon Counting Computed Tomography (PCCT), which allows for the detection of small lesions and subtle pathological changes. By enabling AI-integrated imaging and precise material identification, Redlen supports global partners in improving diagnostic accuracy and safety.